Scarica l'app Stockscreener
2.34
4.46%
0.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Quince Therapeutics, Inc. (IRLA) 경영진 분석 - Simply Wall Street
Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease - The Manila Times
Latham & Watkins Advises on Rocket Pharmaceuticals’ Growth Facility - Latham & Watkins LLP
Rocket secures up to USD 150 million: what it means for Rocket Pharmaceuticals stock - AD HOC NEWS
Rocket secures up to USD 150 million: what it means for Rocket Pharmaceuticals stock - AD HOC NEWS
Rocket Pharmaceuticals Secures $150M Senior Secured Term Loan with Hercules Capital, Issues Warrants - Kalkine Media
Rocket Pharmaceuticals secures $150M credit facility - Investing.com
Rocket Pharmaceuticals secures $150M credit facility with Hercules Capital - StreetInsider
Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital - Business Wire
Have Insiders Sold Rocket Pharmaceuticals Shares Recently? - simplywall.st
Rocket Pharmaceuticals general counsel sells $256,463 in RCKT shares By Investing.com - Investing.com UK
Rocket Pharmaceuticals general counsel sells $256,463 in RCKT shares By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals general counsel sells $256,463 in RCKT shares By Investing.com - Investing.com Canada
Rocket Pharmaceuticals general counsel sells $256,463 in RCKT shares By Investing.com - Investing.com Nigeria
Rocket Pharmaceuticals (RCKT) counsel sells shares to cover RSU tax bill - Stock Titan
Former Rocket Pharmaceuticals (RCKT) executive plans stock sale tied to equity award taxes - Stock Titan
RCKT 8-K FilingsRocket Pharmaceuticals, Inc. SEC 8-K - Stock Titan
Rocket Pharmaceuticals general counsel sells $256,463 in RCKT shares - Investing.com
Three patients count toward Rocket’s 12-patient gene therapy trial - stocktitan.net
Former Rocket Pharmaceuticals (RCKT) officer plans to sell 6,857 shares under an SEC trading rule - Stock Titan
Rocket Pharma (RCKT) executive plans sale of 75K shares tied to vested stock taxes - Stock Titan
Former Rocket Pharma (NASDAQ: RCKT) exec plans stock sale - Stock Titan
Rocket Pharmaceuticals at cantor healthcare conference: cardiomyopathy focus By Investing.com - Investing.com Canada
Rocket Pharmaceuticals at cantor healthcare conference: cardiomyopathy focus By Investing.com - Investing.com India
Rocket Pharmaceuticals at cantor healthcare conference: cardiomyopathy focus - Investing.com
Rocket Pharmaceuticals (RCKT) Up 6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
RCKT News | ROCKET PHARMACEUTICALS INC (NASDAQ:RCKT) - ChartMill
Rocket Pharmaceuticals Inc. (RCKT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance
Rocket Pharma (NASDAQ: RCKT) to pull 2026 warrant listing - Stock Titan
RCKT Maintained by Chardan Capital -- Price Target Stays at $11. - GuruFocus
Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating By Investing.com - Investing.com Nigeria
Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating - Investing.com
Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating By Investing.com - Investing.com Canada
Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating By Investing.com - Investing.com India
Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating By Investing.com - Investing.com UK
Rocket Pharmaceuticals (RCKT) Jumps 6.6% to $3.86 as Buyers Defend Key Support LevelGap Up Stocks - vinanet.vn
New Jersey's Rocket Pharma Strikes New Pay Deal For Its GC - Law360
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - GuruFocus
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock By Investing.com - Investing.com Nigeria
Rocket Pharmaceuticals CEO Gaurav Shah sells $7,752 in shares By Investing.com - Investing.com Nigeria
Rocket Pharmaceuticals CEO Gaurav Shah sells $7,752 in shares - Investing.com
Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals CEO Gaurav Shah sells $7,752 in shares By Investing.com - Investing.com India
Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock By Investing.com - Investing.com India
Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock By Investing.com - Investing.com UK
Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock - Investing.com
Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock - investing.com
1.08%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):